Discovery Spark is back, and Discovery Park are now accepting applications for the next cohort!
If you're pioneering in Biotech, MedTech, Diagnostics, Advanced Therapies, or beyond, this free and unique programme is tailor-made to help you overcome the hurdles of early-stage growth and scale your business with confidence.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…